Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration DOI Creative Commons

Sara Xue,

Brian M. Lozinski, Samira Ghorbani

и другие.

Journal of Neuroscience, Год журнала: 2023, Номер 43(25), С. 4725 - 4737

Опубликована: Май 19, 2023

Aging is a significant risk factor associated with the progression of CNS neurodegenerative diseases including multiple sclerosis (MS). Microglia, resident macrophages parenchyma, are major population immune cells that accumulate in MS lesions. While they normally regulate tissue homeostasis and facilitate clearance neurotoxic molecules oxidized phosphatidylcholines (OxPCs), their transcriptome neuroprotective functions reprogrammed by aging. Thus, determining factors instigate aging microglia dysfunction can lead to new insights for promoting repair halting disease progression. Through single-cell RNA sequencing (scRNAseq), we identified Lgals3, which encodes galectin-3 (Gal3), as an age upregulated gene responding OxPC. Consistently, excess Gal3 accumulated OxPC lysolecithin-induced focal spinal cord white matter (SCWM) lesions middle-aged mice compared young mice. was also elevated mouse experimental autoimmune encephalomyelitis (EAE) more importantly brain from two male one female individuals. delivery alone into did not induce damage, its co-delivery increased cleaved caspase 3 IL-1β within exacerbated OxPC-induced injury. Conversely, OxPC-mediated neurodegeneration reduced Gal3-/- Gal3+/+ neuroinflammation overexpression microglia/macrophages may be detrimental CNS.SIGNIFICANCE STATEMENT accelerates such Understanding molecular mechanisms increases susceptibility damage could strategies manage Here, highlight microglia/macrophage-associated (Gal3) More importantly, co-injection lipids found lesions, caused greater injection alone, whereas genetic loss damage. These results demonstrate suggest deposition contribute neurodegeneration.

Язык: Английский

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases DOI Creative Commons
Jian Sheng Loh, Wen Qi Mak, Li Tan

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2024, Номер 9(1)

Опубликована: Фев. 16, 2024

Abstract The human gastrointestinal tract is populated with a diverse microbial community. vast genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every aspect biology, including health maintenance, development, aging, disease. advent new sequencing technologies culture-independent methods has allowed researchers to move beyond correlative studies toward mechanistic explorations shed light on microbiome–host interactions. Evidence unveiled bidirectional communication between central nervous system, referred as “microbiota–gut–brain axis”. microbiota–gut–brain axis represents an important regulator glial functions, making it actionable target ameliorate development progression neurodegenerative diseases. In this review, we discuss mechanisms As provides essential cues microglia, astrocytes, oligodendrocytes, examine communications microbiota these cells during healthy states Subsequently, diseases using metabolite-centric approach, while also examining role microbiota-related neurotransmitters hormones. Next, targeting intestinal barrier, blood–brain meninges, peripheral immune system counteract dysfunction neurodegeneration. Finally, conclude by assessing pre-clinical clinical evidence probiotics, prebiotics, fecal transplantation A thorough comprehension will foster effective therapeutic interventions for management

Язык: Английский

Процитировано

237

The biology of TREM receptors DOI Open Access
Marco Colonna

Nature reviews. Immunology, Год журнала: 2023, Номер 23(9), С. 580 - 594

Опубликована: Фев. 7, 2023

Язык: Английский

Процитировано

185

TREM2 dependent and independent functions of microglia in Alzheimer’s disease DOI Creative Commons
Jinchao Hou, Yun Chen,

Gary E. Grajales‐Reyes

и другие.

Molecular Neurodegeneration, Год журнала: 2022, Номер 17(1)

Опубликована: Дек. 23, 2022

Abstract Microglia are central players in brain innate immunity and have been the subject of extensive research Alzheimer’s disease (AD). In this review, we aim to summarize genetic functional discoveries that advanced our understanding microglia reactivity AD pathology. Given heightened risk posed by rare variants microglial triggering receptor expressed on myeloid cells 2 (TREM2), will focus studies addressing impact responses amyloid plaques, tauopathy demyelination pathologies mouse human. Finally, discuss implications recent TREM2 biology potential therapeutic strategies for AD.

Язык: Английский

Процитировано

92

Molecular and metabolic heterogeneity of astrocytes and microglia DOI Creative Commons
Philip Hasel, William H. Aisenberg, F. Chris Bennett

и другие.

Cell Metabolism, Год журнала: 2023, Номер 35(4), С. 555 - 570

Опубликована: Март 22, 2023

Язык: Английский

Процитировано

57

Roles and regulation of microglia activity in multiple sclerosis: insights from animal models DOI
Félix Distéfano‐Gagné, Sara Bitarafan, Steve Lacroix

и другие.

Nature reviews. Neuroscience, Год журнала: 2023, Номер 24(7), С. 397 - 415

Опубликована: Июнь 2, 2023

Язык: Английский

Процитировано

56

A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer’s disease DOI Creative Commons
Yongjin Yoo,

Gernot Neumayer,

Yohei Shibuya

и другие.

Cell stem cell, Год журнала: 2023, Номер 30(8), С. 1043 - 1053.e6

Опубликована: Авг. 1, 2023

Язык: Английский

Процитировано

55

Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2 DOI Creative Commons
Yu Chen, Eleonora M. Lad, Rose Mathew

и другие.

The Journal of Experimental Medicine, Год журнала: 2024, Номер 221(3)

Опубликована: Янв. 30, 2024

Outer retinal degenerations, including age-related macular degeneration (AMD), are characterized by photoreceptor and pigment epithelium (RPE) atrophy. In these blinding diseases, macrophages accumulate at atrophic sites, but their ontogeny niche specialization remain poorly understood, especially in humans. We uncovered a unique profile of microglia, marked galectin-3 upregulation, sites mouse models human AMD. disease models, conditional deletion microglia led to phagocytosis defects consequent augmented death, RPE damage, vision loss, indicating protective roles. Mechanistically, Trem2 signaling orchestrated microglial migration induced expression. Moreover, pharmacologic agonization heightened protection galectin-3–dependent manner. elderly subjects, we identified this highly conserved population that expressed Trem2. This was significantly enriched the RPE-choroid AMD subjects. Collectively, our findings reveal neuroprotective potential therapeutic target for mitigating degeneration.

Язык: Английский

Процитировано

23

Innate immune activation in neurodegenerative diseases DOI
Sergio Castro‐Gomez, Michael T. Heneka

Immunity, Год журнала: 2024, Номер 57(4), С. 790 - 814

Опубликована: Апрель 1, 2024

Язык: Английский

Процитировано

21

Microglia and amyloid plaque formation in Alzheimer's disease – Evidence, possible mechanisms, and future challenges DOI Creative Commons
Stefanie Fruhwürth, Henrik Zetterberg, Søren R. Paludan

и другие.

Journal of Neuroimmunology, Год журнала: 2024, Номер 390, С. 578342 - 578342

Опубликована: Апрель 5, 2024

Alzheimer's disease (AD) is a neurodegenerative characterized by cognitive decline that severely affects patients and their families. Genetic environmental risk factors, such as viral infections, synergize to accelerate the aging-associated neurodegeneration. factors for late-onset AD (LOAD), which accounts most cases, are predominantly implicated in microglial immune cell functions. As such, microglia play major role amyloid beta (Aβ) plaque (the pathological hallmark of AD) formation. This review aims provide an overview current knowledge regarding Aβ formation, well impact on morphological functional diversity plaques. Based this discussion, we seek identify challenges opportunities field with potential therapeutic implications.

Язык: Английский

Процитировано

21

Immune Activation in Alzheimer Disease DOI
Arnaud Mary, Renzo Mancuso, Michael T. Heneka

и другие.

Annual Review of Immunology, Год журнала: 2024, Номер 42(1), С. 585 - 613

Опубликована: Март 1, 2024

Alzheimer disease (AD) is the most common neurodegenerative disease, and with no efficient curative treatment available, its medical, social, economic burdens are expected to dramatically increase. AD historically characterized by amyloid β (Aβ) plaques tau neurofibrillary tangles, but over last 25 years chronic immune activation has been identified as an important factor contributing pathogenesis. In this article, we review recent advances in our understanding of significance development AD. We describe how brain-resident macrophages, microglia, able detect Aβ species be activated, well consequences activated microglia discuss transcriptional changes AD, their unique heterogeneity humans, emerging strategies study human microglia. Finally, expose, beyond role peripheral signals different cell types activation.

Язык: Английский

Процитировано

19